Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.
Front Immunol
; 13: 898151, 2022.
Article
en En
| MEDLINE
| ID: mdl-35812412
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Vacunas
/
COVID-19
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
Front Immunol
Año:
2022
Tipo del documento:
Article